Possible genotoxic effects of dapagliflozin using SMART and comet tests, and behavioral toxicity in Drosophila melanogaster
{{output}}
Dapagliflozin (DAPA) is a sodium-glucose cotransporter (SGLT) inhibitor used in the treatment of type 2 diabetes mellitus. DAPA, used in the treatment of type 2 diabetes mellitus (T2DM), has been shown to cause liver damage in clinical studies, and has raised ... ...
